Automation of cellular therapy product manufacturing: results of a split validation comparing CD34 selection of peripheral blood stem cell apheresis product with a semi-manual vs. an automatic procedure

BACKGROUND: Automation of cell therapy manufacturing promises higher productivity of cell factories, more economical use of highly-trained (and costly) manufacturing staff, facilitation of processes requiring manufacturing steps at inconvenient hours, improved consistency of processing steps and oth...

Descripción completa

Detalles Bibliográficos
Autores principales: Hümmer, Christiane, Poppe, Carolin, Bunos, Milica, Stock, Belinda, Wingenfeld, Eva, Huppert, Volker, Stuth, Juliane, Reck, Kristina, Essl, Mike, Seifried, Erhard, Bonig, Halvard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793541/
https://www.ncbi.nlm.nih.gov/pubmed/26983643
http://dx.doi.org/10.1186/s12967-016-0826-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793541/
https://www.ncbi.nlm.nih.gov/pubmed/26983643
http://dx.doi.org/10.1186/s12967-016-0826-8

Ejemplares similares